To the best of our knowledge, we are the first group to report that the correlation of MAP1LC3B and SQSTM1 with clinicopathological outcomes at certain subsites using the largest cohort, comprising 498 paired tumor and adjacent normal tissues of OSCC. The gene discussed is MAP1LC3B; the disease is neoplasm.